Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025
Nuwellis (NUWE), a commercial-stage medical technology company specializing in fluid overload solutions, has scheduled its first quarter 2025 financial results announcement for May 13, 2025. The company will host a conference call and webcast at 9:00 AM ET to discuss the results and provide a business update.
Investors can access the live webcast through the company's investor relations website at ir.nuwellis.com, or join the conference call by dialing 1-800-579-2543 (U.S.) or 1-785-424-1789 (international) using conference ID: NUWEQ1. An audio recording will be available on the company's investor website after the call.
Nuwellis (NUWE), un'azienda di tecnologia medica in fase commerciale specializzata in soluzioni per il sovraccarico di liquidi, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 13 maggio 2025. La società terrà una conference call e una webcast alle 9:00 AM ET per discutere i risultati e fornire un aggiornamento sull'attività.
Gli investitori potranno seguire la diretta streaming tramite il sito web per gli investitori della società all'indirizzo ir.nuwellis.com, oppure partecipare alla conference call chiamando il numero 1-800-579-2543 (USA) o 1-785-424-1789 (internazionale) utilizzando il codice conferenza: NUWEQ1. Una registrazione audio sarà disponibile sul sito degli investitori dopo la chiamata.
Nuwellis (NUWE), una empresa de tecnología médica en etapa comercial especializada en soluciones para la sobrecarga de líquidos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 13 de mayo de 2025. La compañía realizará una llamada conferencia y una transmisión en vivo a las 9:00 AM ET para discutir los resultados y ofrecer una actualización del negocio.
Los inversionistas podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de la empresa en ir.nuwellis.com, o unirse a la llamada conferencia marcando 1-800-579-2543 (EE. UU.) o 1-785-424-1789 (internacional) usando el ID de conferencia: NUWEQ1. Una grabación de audio estará disponible en el sitio web para inversionistas después de la llamada.
Nuwellis (NUWE)는 체액 과부하 솔루션을 전문으로 하는 상업 단계 의료 기술 회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 13일에 예정하고 있습니다. 회사는 동부 표준시 오전 9시에 컨퍼런스 콜과 웹캐스트를 통해 실적을 논의하고 사업 현황을 업데이트할 예정입니다.
투자자들은 회사 투자자 관계 웹사이트 ir.nuwellis.com을 통해 라이브 웹캐스트에 접속할 수 있으며, 컨퍼런스 ID: NUWEQ1을 사용하여 미국 내 1-800-579-2543 또는 국제적으로 1-785-424-1789번으로 전화하여 컨퍼런스 콜에 참여할 수 있습니다. 통화 후 회사 투자자 웹사이트에 오디오 녹음이 제공될 예정입니다.
Nuwellis (NUWE), une entreprise de technologie médicale en phase commerciale spécialisée dans les solutions de surcharge liquidienne, a prévu d’annoncer ses résultats financiers du premier trimestre 2025 le 13 mai 2025. La société organisera une conférence téléphonique et un webinaire à 9h00 ET pour discuter des résultats et fournir une mise à jour sur ses activités.
Les investisseurs peuvent accéder au webinaire en direct via le site des relations investisseurs de la société à ir.nuwellis.com, ou rejoindre la conférence téléphonique en composant le 1-800-579-2543 (États-Unis) ou le 1-785-424-1789 (international) avec l’identifiant de conférence : NUWEQ1. Un enregistrement audio sera disponible sur le site des investisseurs après l’appel.
Nuwellis (NUWE), ein medizinisches Technologieunternehmen in der kommerziellen Phase, das sich auf Lösungen bei Flüssigkeitsüberladung spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 13. Mai 2025 geplant. Das Unternehmen wird um 9:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben.
Investoren können den Live-Webcast über die Investor-Relations-Website des Unternehmens unter ir.nuwellis.com verfolgen oder sich per Telefon unter 1-800-579-2543 (USA) oder 1-785-424-1789 (international) mit der Konferenz-ID: NUWEQ1 einwählen. Eine Audioaufzeichnung wird nach dem Anruf auf der Investor-Website verfügbar sein.
- None.
- None.
MINNEAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter 2025 on May 13, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.
To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-579-2543 (U.S) or 1-785-424-1789 (international) and using the conference ID: NUWEQ1. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a commercial-stage medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit ir.nuwellis.com or visit us on LinkedIn or X.
About the Aquadex SmartFlow® System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
CONTACTS
INVESTORS:
Louisa Smith
Gilmartin Group LLC
ir@nuwellis.com
FAQ
When will Nuwellis (NUWE) release its Q1 2025 earnings?
How can investors join the Nuwellis (NUWE) Q1 2025 earnings call?
What time is the Nuwellis (NUWE) Q1 2025 earnings conference call?
What is Nuwellis's (NUWE) main business focus?
